The company's customers range from individual inventors to Fortune 500 companies, and it monetizes of its patent portfolio by licensing it to individual companies or parties. Marathon owns over 500 patents; however, its market cap is a meager 19M.
A week ago, Marathon announced it received a formal notification from the NASDAQ Stock Market stating the company had regained compliance for continued listing on NASDAQ. Hence Marathon's common shares will continue to trade on NASDAQ.